Have a personal or library account? Click to login
The effects of Antidepressant Therapy on Health-Related Quality of Life in Patients with a Chronic Obstructive Pulmonary Disease and Depressive Symptoms Cover

The effects of Antidepressant Therapy on Health-Related Quality of Life in Patients with a Chronic Obstructive Pulmonary Disease and Depressive Symptoms

EABR. Experimental and Applied Biomedical Research
Volume 25 (2024): Issue 3 (September 2024)
By: Ivana Jelic,  Marko Folic,  Filip Mihajlovic,  Slobodan Jankovic and  Goran Mihajlovic  
Open Access
|Jan 2022

Authors

Ivana Jelic

jelicivana82@yahoo.com

University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia

Marko Folic

University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Clinical Pharmacology Department, University Clinical Centre Kragujevac, Kragujevac, Serbia

Filip Mihajlovic

University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia

Slobodan Jankovic

University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Clinical Pharmacology Department, University Clinical Centre Kragujevac, Kragujevac, Serbia

Goran Mihajlovic

University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Psychiatry Clinic, University Clinical Centre Kragujevac, Kragujevac, Serbia
DOI: https://doi.org/10.2478/sjecr-2021-0068 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 243 - 248
Submitted on: Nov 18, 2021
|
Accepted on: Dec 19, 2021
|
Published on: Jan 17, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Chronic obstructive pulmonary disease,
depression,
antidepressants,
quality of life
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2022 Ivana Jelic, Marko Folic, Filip Mihajlovic, Slobodan Jankovic, Goran Mihajlovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 25 (2024): Issue 3 (September 2024)Next article